ACE-inhibitor 发表于 2025-3-23 11:39:29
http://reply.papertrans.cn/29/2849/284834/284834_11.png核心 发表于 2025-3-23 17:52:25
http://reply.papertrans.cn/29/2849/284834/284834_12.pngPeristalsis 发表于 2025-3-23 21:54:58
Mohammed TariqueReviews novel molecular targets for antimalarial drug development.Explores metabolic enzymes as druggable targets against malaria.Examines Plasmodium Kinases as potential drug targets for malariaGUISE 发表于 2025-3-23 23:31:45
http://image.papertrans.cn/e/image/284834.jpgLATHE 发表于 2025-3-24 05:24:01
Vitamin D Assays and Their Clinical Utility,untries, it poses serious clinical and economic challenges. Malaria is caused by parasitic organisms of the genus Plasmodium, which are single-celled protozoans. In addition to humans, these parasites infect a wide variety of other species. There are more than 200 formally characterized species of P让步 发表于 2025-3-24 07:37:44
http://reply.papertrans.cn/29/2849/284834/284834_16.pngCerebrovascular 发表于 2025-3-24 12:56:31
http://reply.papertrans.cn/29/2849/284834/284834_17.pngprojectile 发表于 2025-3-24 16:48:40
http://reply.papertrans.cn/29/2849/284834/284834_18.png不透明 发表于 2025-3-24 22:03:37
http://reply.papertrans.cn/29/2849/284834/284834_19.pngPLAYS 发表于 2025-3-25 02:34:55
Onyeka Obioha,Candrice Heath,Pearl E. Grimescancer, immune deficiencies, viral infection, and neurodegenerative disease leading to the successful clinical development of effective and selective inhibitors of phosphoinositide kinases. However, targeting of phosphoinositide kinases is most effective for plasmodium to treat malaria. The phosphat